Women with endometrial cancer who are found to have lymph-node-positive disease during surgical staging by lymphadenectomy benefit from adjuvant chemotherapy; however, the remaining 78% of women who ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.7% in the last trading session to close at $22.36. The move was backed by solid volume with far more shares changing hands than in a normal ...

Silence Therapeutics Plc (NASDAQ:SLN) shares are trading lower in the morning session on Wednesday. The company reported a loss per share of (38.9) pence for 2023, narrower than the (41.9) pence loss ...

Shares of Silence Therapeutics PLC Sponsored ADR (SLN) have gained 52% over the past four weeks to close the last trading session at $5.41, but there could still be a solid upside left in the stock if ...

With a view to the signing of the Pacte Nickel (Nickel Pact), Eramet and the French State have reached an agreement to extend the financial guarantees granted to SLN, enabling SLN to continue to run ...

View Silence Therapeutics PLC Sponsored ADR SLN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Silence Therapeutics PLC Sponsored ADR (SLN) shares rallied 19% in the last trading session to close at $7.28. This move can be attributable to notable volume with a higher number of shares being ...